Annual SG&A
$32.37 M
+$1.63 M+5.29%
31 December 2023
Summary:
Foghorn Therapeutics annual selling, general & administrative expenses is currently $32.37 million, with the most recent change of +$1.63 million (+5.29%) on 31 December 2023. During the last 3 years, it has risen by +$21.13 million (+187.85%). FHTX annual SG&A is now at all-time high.FHTX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$6.97 M
-$354.00 K-4.83%
30 September 2024
Summary:
Foghorn Therapeutics quarterly selling, general & administrative expenses is currently $6.97 million, with the most recent change of -$354.00 thousand (-4.83%) on 30 September 2024. Over the past year, it has dropped by -$1.34 million (-16.09%). FHTX quarterly SG&A is now -19.33% below its all-time high of $8.64 million, reached on 31 March 2023.FHTX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$2.03 B
-$91.22 M-4.71%
30 September 2024
Summary:
Foghorn Therapeutics TTM selling, general & administrative expenses is currently -$2.03 billion, with the most recent change of -$91.22 million (-4.71%) on 30 September 2024. Over the past year, it has dropped by -$2.06 billion (-6201.36%). FHTX TTM SG&A is now -2052.61% below its all-time high of $33.21 million, reached on 30 September 2023.FHTX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FHTX Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.3% | -16.1% | -6201.4% |
| 3 y3 years | +187.8% | +20.0% | -10000.0% |
| 5 y5 years | +571.1% | +285.6% | -10000.0% |
FHTX Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +187.8% | -19.3% | +20.0% | -155.5% | at low |
| 5 y | 5 years | at high | +571.1% | -19.3% | +318.4% | -2052.6% | at low |
| alltime | all time | at high | +571.1% | -19.3% | +318.4% | -2052.6% | at low |
Foghorn Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $6.97 M(-4.8%) | $29.03 M(-4.4%) |
| June 2024 | - | $7.33 M(-5.0%) | $30.36 M(-3.4%) |
| Mar 2024 | - | $7.71 M(+9.8%) | $31.44 M(-2.9%) |
| Dec 2023 | $32.37 M(+5.3%) | $7.02 M(-15.5%) | $32.37 M(-2.5%) |
| Sept 2023 | - | $8.31 M(-1.1%) | $33.21 M(+1.0%) |
| June 2023 | - | $8.40 M(-2.8%) | $32.87 M(+2.2%) |
| Mar 2023 | - | $8.64 M(+9.9%) | $32.17 M(+4.6%) |
| Dec 2022 | $30.75 M(+41.5%) | $7.86 M(-1.3%) | $30.75 M(+5.2%) |
| Sept 2022 | - | $7.96 M(+3.4%) | $29.22 M(+8.0%) |
| June 2022 | - | $7.70 M(+6.8%) | $27.06 M(+11.6%) |
| Mar 2022 | - | $7.22 M(+14.0%) | $24.25 M(+11.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $21.73 M(+93.2%) | $6.33 M(+9.0%) | $21.73 M(+8.9%) |
| Sept 2021 | - | $5.81 M(+18.6%) | $19.95 M(+19.5%) |
| June 2021 | - | $4.90 M(+4.4%) | $16.70 M(+21.8%) |
| Mar 2021 | - | $4.69 M(+2.9%) | $13.71 M(+22.0%) |
| Dec 2020 | $11.25 M(+67.3%) | $4.56 M(+78.4%) | $11.25 M(+34.6%) |
| Sept 2020 | - | $2.56 M(+33.7%) | $8.35 M(+9.8%) |
| June 2020 | - | $1.91 M(-14.0%) | $7.61 M(+33.6%) |
| Mar 2020 | - | $2.22 M(+33.3%) | $5.70 M(+63.9%) |
| Dec 2019 | $6.72 M(+39.3%) | $1.67 M(-7.9%) | $3.47 M(+92.1%) |
| Sept 2019 | - | $1.81 M | $1.81 M |
| Dec 2018 | $4.82 M | - | - |
FAQ
- What is Foghorn Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Foghorn Therapeutics?
- What is Foghorn Therapeutics annual SG&A year-on-year change?
- What is Foghorn Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Foghorn Therapeutics?
- What is Foghorn Therapeutics quarterly SG&A year-on-year change?
- What is Foghorn Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Foghorn Therapeutics?
- What is Foghorn Therapeutics TTM SG&A year-on-year change?
What is Foghorn Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of FHTX is $32.37 M
What is the all time high annual SG&A for Foghorn Therapeutics?
Foghorn Therapeutics all-time high annual selling, general & administrative expenses is $32.37 M
What is Foghorn Therapeutics annual SG&A year-on-year change?
Over the past year, FHTX annual selling, general & administrative expenses has changed by +$1.63 M (+5.29%)
What is Foghorn Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of FHTX is $6.97 M
What is the all time high quarterly SG&A for Foghorn Therapeutics?
Foghorn Therapeutics all-time high quarterly selling, general & administrative expenses is $8.64 M
What is Foghorn Therapeutics quarterly SG&A year-on-year change?
Over the past year, FHTX quarterly selling, general & administrative expenses has changed by -$1.34 M (-16.09%)
What is Foghorn Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of FHTX is -$2.03 B
What is the all time high TTM SG&A for Foghorn Therapeutics?
Foghorn Therapeutics all-time high TTM selling, general & administrative expenses is $33.21 M
What is Foghorn Therapeutics TTM SG&A year-on-year change?
Over the past year, FHTX TTM selling, general & administrative expenses has changed by -$2.06 B (-6201.36%)